Ranexa
Product Images NDC 68151-5004

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranexa (NDC 68151-5004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681515004)

Label for Ranexa ranolazine 500 mg extended-release tablets manufactured by Gilead, showing lot number 002409 and expiration date 07/14. The label includes a barcode and indicates prescription use (Rx only).*

FDA Label Image

Chemical Structure (Ranexa 01)

Chemical structure of Ranexa's active ingredient, depicted as a detailed molecular diagram featuring various chemical bonds and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.